Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Breastfeeding Journal
Published in: International Breastfeeding Journal 1/2016

Open Access 01-12-2016 | Commentary

Probiotics and mastitis: evidence-based marketing?

Authors: Lisa H. Amir, Laura Griffin, Meabh Cullinane, Suzanne M. Garland

Published in: International Breastfeeding Journal | Issue 1/2016

Login to get access

Abstract

Probiotics are defined as live micro-organisms, which when administered in adequate amounts, confer health benefits on the host. Scientists have isolated various strains of Lactobacilli from human milk (such as Lactobacillus fermentum and Lactobacillus salivarius), and the presence of these organisms is thought to be protective against breast infections, or mastitis.
Trials of probiotics for treating mastitis in dairy cows have had mixed results: some successful and others unsuccessful. To date, only one trial of probiotics to treat mastitis in women and one trial to prevent mastitis have been published. Although trials of probiotics to prevent mastitis in breastfeeding women are still in progress, health professionals in Australia are receiving marketing of these products.
High quality randomised controlled trials are needed to assess the effectiveness of probiotics for the prevention and/or treatment of mastitis.
Literature
1.
Blaser MJ. The human microbiome, Missing Microbes: How the overuse of antibiotics is fueling our modern plagues. New York: Henry Holt and Company; 2014. p. 22–39.
2.
Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60(1):49–54.CrossRefPubMed
3.
Blaser M. Antibiotic overuse: Stop the killing of beneficial bacteria. Nature. 2011;476(7361):393–4.CrossRefPubMed
4.
Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96(3):544–51.CrossRefPubMed
5.
Hickey L, Jacobs SE, Garland SM, ProPrems Study Group. Probiotics in neonatology. J Paediatr Child Health. 2012;48(9):777–83.CrossRefPubMed
6.
Garland SM, Tobin JM, Pirotta M, Tabrizi SN, Opie G, Donath S, Tang ML, Morley CJ, Hickey L, Ung L, et al. The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis. 2011;11:210.CrossRefPubMedPubMedCentral
7.
Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, Morley CJ, Garland SM, ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055–62.CrossRefPubMed
8.
Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR, Probiotics in Preterm Infants Study Collaborative G. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet. 2015.
9.
van Loveren H, Sanz Y, Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol. 2012;3:247–61.CrossRefPubMed
10.
AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:CD005496.PubMed
11.
Zuccotti G, Meneghin F, Aceti A, Barone G, Callegari ML, Di Mauro A, Fantini MP, Gori D, Indrio F, Maggio L et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70(11):1356–71.CrossRefPubMed
12.
13.
Olivares M, Diaz-Ropero MP, Martin R, Rodriguez JM, Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol. 2006;101(1):72–9.CrossRefPubMed
14.
Jimenez E, Fernandez L, Maldonado A, Martin R, Olivares M, Xaus J, Rodriguez JM. Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol. 2008;74(15):4650–5.CrossRefPubMedPubMedCentral
15.
Arroyo R, Martin V, Maldonado A, Jimenez E, Fernandez L, Rodriguez JM. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis. 2010;50(12):1551–8.CrossRefPubMed
16.
Martin R, Olivares M, Marin ML, Fernandez L, Xaus J, Rodriguez JM. Probiotic potential of 3 Lactobacilli strains isolated from breast milk. J Hum Lact. 2005;21(1):8–17.CrossRefPubMed
17.
Diaz-Ropero MP, Martin R, Sierra S, Lara-Villoslada F, Rodriguez JM, Xaus J, Olivares M. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007;102(2):337–43.CrossRefPubMed
18.
Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, Serrant P, Segura-Roggero I, Schiffrin EJ, Donnet-Hughes A. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics. 2007;119(3):e724–32.CrossRefPubMed
19.
Donnet-Hughes A, Perez PF, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P, Segura-Roggero I, Schiffrin EJ. Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc Nutr Soc. 2010;69(3):407–15.CrossRefPubMed
20.
Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Bjorksten B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49(3):349–54.CrossRefPubMed
21.
Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr. 2004;38(3):293–7.CrossRefPubMed
22.
Klostermann K, Crispie F, Flynn J, Ross RP, Hill C, Meaney W. Intramammary infusion of a live culture of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials. J Dairy Res. 2008;75(3):365–73.CrossRefPubMed
23.
Greene WA, Gano AM, Smith KL, Hogan JS, Todhunter DA. Comparison of probiotic and antibiotic intramammary therapy of cattle with elevated somatic cell counts. J Dairy Sci. 1991;74(9):2976–81.CrossRefPubMed
24.
Beecher C, Daly M, Berry DP, Klostermann K, Flynn J, Meaney W, Hill C, McCarthy TV, Ross RP, Giblin L. Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression. J Dairy Res. 2009;76(3):340–8.CrossRefPubMed
25.
Crispie F, Alonso-Gomez M, O'Loughlin C, Klostermann K, Flynn J, Arkins S, Meaney W, Paul Ross R, Hill C. Intramammary infusion of a live culture for treatment of bovine mastitis: effect of live lactococci on the mammary immune response. J Dairy Res. 2008;75(3):374–84.CrossRefPubMed
26.
Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol. 2002;34(4):245–53.CrossRefPubMed
27.
Amir LH, The Academy of Breastfeeding Medicine Protocol Committee. ABM Clinical Protocol # 4: Mastitis, Revision, March 2014. Breastfeed Med. 2014;9(5):239–43.CrossRefPubMedPubMedCentral
28.
World Health Organization. Mastitis: Causes and Management. Geneva: WHO/FCH/CAH/00.13; 2000.
29.
Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Melbourne: Therapeutic Guidelines Ltd.; 2010.
30.
Amir LH, Forster D, McLachlan H, Lumley J. Incidence of breast abscess in lactating women: report from an Australian cohort. BJOG. 2004;111(12):1378–81.CrossRefPubMed
31.
Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti Infect Ther. 2014;12(7):753–62.CrossRefPubMed
32.
McDonald K, Amir LH, Davey M-A. Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011;11 Suppl 5:S5.CrossRefPubMedPubMedCentral
33.
Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynec. 2006;107(5):1120–38.CrossRefPubMed
34.
35.
36.
McGuire E, Tawia S. Probiotics are the new black. Breastfeed Rev. 2014;22(3):33–41.PubMed
37.
Fernandez L, Cardenas N, Arroyo R, Manzano S, Jimenez E, Martin V, Rodriguez JM. Prevention of infectious mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy. Clin Infect Dis. 2016;62(5):568–73.CrossRefPubMed
38.
Amir LH, Trupin S, Kvist LJ. Diagnosis and treatment of mastitis in breastfeeding women. J Hum Lact. 2014;30(1):10–3.CrossRefPubMed
39.
40.
41.
42.
Therapeutic Goods Act 1989 (Cth) Chapter 5. 1989.
43.
Therapeutic Goods Advertising Code (Cth). 2007.
44.
45.
Sterling Winthrop Pty Ltd v Boots Co (Aust) Pty Ltd (1995) 32 IPR 361.
46.
47.
Trotman Australia Pty Ltd v Hobsons Press (Aust) Pty Ltd (1991) 22 IPR 397. 403.
48.
Metcalfe v NZI Securities Australia Ltd (1995) ATPR ¶41-418 at 40,671; BC9507736.; 1995.
49.
Janssen Pharmaceutical Pty Ltd v Pfizer Pty Ltd (1985) 6 IPR 227 at 234. 1985.
50.
Peterson v Merck Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1.
51.
Colgate-Palmolive Pty Ltd v Rexona Pty Ltd (1981) 58 FLR 391. 401–402.
52.
Hornsby Building Information Centre Pty Ltd v Sydney Building Information Centre Ltd (1978) 140 CLR 216.
53.
54.
Blaser MJ. Solutions, Missing Microbes: How the overuse of antibiotics is fueling our modern plagues. New York: Henry Holt and Company; 2014. p. 199–217.
55.
Arribas B, Rodriguez-Cabezas ME, Comalada M, Bailon E, Camuesco D, Olivares M, Xaus J, Zarzuelo A, Galvez J. Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr. 2009;101(1):51–8.CrossRefPubMed
Metadata
Title
Probiotics and mastitis: evidence-based marketing?
Authors
Lisa H. Amir
Laura Griffin
Meabh Cullinane
Suzanne M. Garland
Publication date
01-12-2016
Publisher
BioMed Central
Published in
International Breastfeeding Journal / Issue 1/2016
Electronic ISSN: 1746-4358
DOI
https://doi.org/10.1186/s13006-016-0078-5

Other articles of this Issue 1/2016

International Breastfeeding Journal 1/2016 Go to the issue

Research

Prevalence and associated factors of timely initiation of breastfeeding among mothers at Debre Berhan town, Ethiopia: a cross-sectional study

Research

Prevalence and associated factors of non-exclusive breastfeeding of infants during the first six months in rural area of Sorro District, Southern Ethiopia: a cross-sectional study

Research

Determinants of early initiation of breastfeeding in Amibara district, Northeastern Ethiopia: a community based cross-sectional study

Research

Associations between perceived value of exclusive breastfeeding among pregnant women in the United States and exclusive breastfeeding to three and six months postpartum: a prospective study

Research

Factors associated with prelacteal feeding in the rural population of northwest Ethiopia: a community cross-sectional study

Research

Perceptions related to breastfeeding and the early introduction of complementary foods amongst migrants in Cape Town, South Africa